USNA · Usana Health Sciences Inc
$21.45
+0.53 (+2.53%)
At close · Jul 24
Market Cap
$393.63M
Shares
18.46M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$925.26M
+8.3%
FY2026
Net Income
$10.76M
-74.4%
FY2026
Gross Margin
78.29%
-2.8pp
FY2026
Operating Margin
4.05%
-3.7pp
FY2026
Diluted EPS
$0.58
-73.5%
FY2026
Operating Cash Flow
$22.35M
-63.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $925.94M | $925.26MG | $854.5M | $921.01M | $998.6M | $1.19B | $1.13B | $1.06B | $1.19B | $1.05B | $1.01B | — | — | — | — | — | — | — | |
| $207.84M | $200.85M | $161.21M | $176.69M | $193.89M | $217.9M | $209.11M | $187.5M | $200.71M | $179.4M | $180.19M | $159.68M | $140.79M | $127.44M | $115.8M | $101.69M | $95.48M | $89.8M | |
| $718.09M | $724.41M | $693.29M | $744.32M | $804.71M | $968.57M | $925.53M | $873.4M | $988.54M | $867.86M | $825.89M | $758.82M | $649.68M | $590.74M | $532.92M | $480.25M | $422.16M | $347.14M | |
| — | 78.29% | 81.13% | 80.82% | 80.58% | 81.63% | 81.57% | 82.33% | 83.12% | 82.87% | 82.09% | — | — | — | — | — | — | — | |
| — | $10.69M | $11.57M | $11.45M | $11.56M | $11.11M | $10.63M | $10.26M | $10.24M | $8.95M | $8.84M | $6.42M | $5.13M | $5.08M | $4.66M | $4.07M | $3.84M | — | |
| $334.19M | $337.37M | $263.27M | $256.99M | $262.3M | $279.11M | $261.19M | $267.73M | $275.06M | $265.09M | $234.19M | $209M | $184.53M | $166.21M | $154.24M | $137.06M | $120.76M | $99.98M | |
| — | $19.32M | $1.52M | $1.84M | $1.72M | $1.18M | $1.33M | $1.44M | $1.51M | $1.48M | $1.5M | $900K | $431K | $897K | $1.09M | $1.52M | — | — | |
| $32.5M | $32.56M | $14.54M | $12.7M | $13.39M | $13.04M | $13.75M | $14.74M | $16.84M | $16.11M | $13.48M | $9.98M | $8.81M | $9.04M | $8.83M | $8.47M | $7.92M | $7.07M | |
| — | $6.46M | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $682.46M | $686.97M | $626.97M | $651.25M | $697.1M | $798.37M | $749.04M | $727.21M | $800.19M | $735.36M | $687.27M | $617.16M | $533.58M | $474.03M | $434.74M | $402.99M | $353.95M | $296.35M | |
| $35.64M | $37.43M | $66.32M | $93.07M | $107.61M | $170.19M | $176.49M | $146.19M | $188.35M | $132.5M | $138.62M | $141.66M | $116.1M | $116.71M | $98.18M | $77.26M | $68.22M | $50.79M | |
| — | 4.05% | 7.76% | 10.11% | 10.78% | 14.34% | 15.55% | 13.78% | 15.84% | 12.65% | 13.78% | — | — | — | — | — | — | — | |
| $68.14M | $69.99M | $80.86M | $105.77M | $121.01M | $183.23M | $190.24M | $160.93M | $205.2M | $148.61M | $152.1M | $151.64M | $124.91M | $125.76M | $107.01M | $85.73M | $76.13M | $57.86M | |
| $671K | $842K | $281K | $262K | $192K | $57K | $507K | $66K | $36K | $46K | $444K | $15K | $129K | $1000 | $20K | $9000 | $94K | $609K | |
| $2.13M | $2.42M | $11.32M | $9.64M | $3.79M | $2.52M | $2.54M | $4.71M | $4.43M | $2.19M | $1.48M | $1.12M | $500K | $464K | $247K | $191K | $167K | $82K | |
| $4.62M | $4.1M | $10.03M | $9.38M | $1.01M | $450K | $1.46M | $4.31M | $3.16M | $2.14M | -$70K | $927K | -$449K | -$131K | $247K | $222K | $648K | $187K | |
| $40.25M | $41.53M | $76.35M | $102.45M | $108.62M | $170.64M | $177.95M | $150.5M | $191.51M | $134.64M | $138.55M | $142.59M | $115.65M | $116.58M | $98.43M | $77.48M | $68.86M | $50.98M | |
| $31.11M | $30.05M | $34.29M | $38.67M | $39.27M | $54.14M | $53.28M | $49.97M | $65.29M | $72.11M | $38.51M | $47.92M | $39.02M | $37.56M | $31.99M | $26.73M | $23.21M | $17.42M | |
| $8.87M | $10.76M | $42.03M | $63.79M | $69.35M | $116.51M | $124.66M | $100.53M | $126.22M | $62.54M | $100.04M | $94.67M | $76.64M | $79.02M | $66.43M | $50.75M | $45.65M | $33.56M | |
| — | 1.16% | 4.92% | 6.93% | 6.94% | 9.82% | 10.99% | 9.48% | 10.61% | 5.97% | 9.94% | — | — | — | — | — | — | — | |
| $54.34M | — | — | $63.79M | $69.35M | $116.51M | $124.66M | $100.53M | $126.22M | $62.54M | $100.04M | $94.67M | $76.64M | $79.02M | $66.43M | $50.75M | $45.65M | — | |
| $17.19M | $17.25M | $33.06M | $62.88M | $56.11M | $120.59M | $134.94M | $97.01M | $117.26M | $72.76M | $92.17M | $88.76M | $72.97M | $77.88M | $67.53M | $51.23M | $49.49M | — | |
| USD/shares | — | $0.58 | $2.20 | $3.31 | $3.60 | $5.78 | $5.89 | $4.44 | $5.24 | $2.57 | $4.14 | $3.72 | $2.90 | $5.77 | $4.57 | $3.30 | $2.94 | $2.19 |
| USD/shares | — | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 | $5.86 | $4.41 | $5.12 | $2.53 | $3.99 | $3.59 | $2.80 | $5.56 | $4.45 | $3.26 | $2.86 | $2.17 |
| shares | — | 18.54M | 19.1M | 19.25M | 19.25M | 20.15M | 21.16M | 22.64M | 24.11M | 24.35M | 24.19M | 25.46M | 26.44M | 13.7M | 14.55M | 15.36M | 15.53M | 15.34M |
| shares | — | 18.57M | 19.16M | 19.35M | 19.31M | 20.34M | 21.26M | 22.82M | 24.64M | 24.71M | 25.05M | 26.36M | 27.38M | 14.2M | 14.92M | 15.57M | 15.94M | 15.43M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2010–FY2026: $1.02B in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Packaged Foods median 1.24×
EV/EBIT
—
Packaged Foods median 15.14×
P/E (TTM)
42.64×
Packaged Foods median 15.23×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Core Nutritional | $775,452,000 | $845,789,000 | $915,212,000 | — | — | — |
| Hiya | $131,971,000 | $1,970,000 | — | — | — | — |
| All Other | $17,834,000 | $6,744,000 | $5,798,000 | $3,559,000 | $0 | $0 |
| Direct Selling | — | — | — | $995,042,000 | $1,186,464,000 | $1,134,644,000 |
By Geography (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Greater China | $424,541,000 | $457,976,000 | $475,099,000 | $502,486,000 | $563,469,000 | $530,505,000 | $535,995,000 | $654,394,000 |
| China | $381,816,000 | $413,471,000 | $427,265,000 | $453,134,000 | $506,103,000 | $470,177,000 | $471,165,000 | $586,518,000 |
| Americas and Europe | $298,093,000 | $171,518,000 | $180,575,000 | $196,685,000 | $223,272,000 | $219,620,000 | $208,635,000 | $232,665,000 |
| United States | $224,890,000 | $91,796,000 | $95,906,000 | $106,087,000 | $125,835,000 | $107,323,000 | $105,111,000 | $116,299,000 |
| Southeast Asia Pacific | $131,996,000 | $146,795,000 | $163,890,000 | $190,478,000 | $269,803,000 | $269,555,000 | $220,085,000 | $225,469,000 |
| North Asia | $70,627,000 | $78,214,000 | $101,446,000 | $108,952,000 | $129,920,000 | $114,964,000 | $96,187,000 | $76,720,000 |
| South Korea | $68,856,000 | $76,445,000 | $99,108,000 | $106,391,000 | $110,379,000 | $110,807,000 | $92,919,000 | — |
| Southeast Asia and Pacific | — | — | — | — | — | — | $220,085,000 | $225,469,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Core Nutritional | $40,507,000 | $70,779,000 | $96,353,000 | — |
| Hiya | $3,406,000 | $146,000 | — | — |
| All Other | -$6,481,000 | -$4,601,000 | -$3,282,000 | -$1,884,000 |
| Direct Selling | — | — | — | $109,498,000 |
Operating Margin by Segment (%)
| Component | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Core Nutritional | 5.2% | 8.4% | 10.5% | — |
| Hiya | 2.6% | 7.4% | — | — |
| All Other | -36.3% | -68.2% | -56.6% | -52.9% |
| Direct Selling | — | — | — | 11% |
Key facts
CIK
896264
CUSIP
90328M107
13F (30d)
19 filings
19 filers
Visit website
Investor relations